Details of the Drug

General Information of Drug (ID: DM3N6ME)

• Drug Name: MDR-102

Indication

Disease Entry	ICD 11	Status	REF
Kidney transplant rejection	NE84	Phase 2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D8ZNW0

References

• [1] ClinicalTrials.gov (NCT03605654) Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants. U.S. National Institutes of Health.